Shuaishuai Zhang

8PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesChemical and thermal processes in energy and combustionApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 09, 2026
Extracellular matrix-targeted TNC-scFv armoring enhances CAR T cell persistence and antitumor activity in solid tumors.

|Jan 09, 2026
Isobavachin Ameliorates Acetaminophen-Induced Liver Injury Through Modulation of CYP2E1-Mediated Bioactivation and NRF2/PI3K/AKT Cytoprotective Pathways.

Wenjie Ye, Shuaishuai Zhang, Youxi Zhou

|Nov 11, 2025
TNC-targeted CAR-macrophage therapy alleviates liver fibrosis in mice.

Kai-Zhao Chen, Zi-Yang Lin, Long-Jun Chen

|Mar 26, 2025
Recent Advances in Polysaccharide-Based Hydrogels for Tumor Immunotherapy.

Youxi Zhou, Kaizhao Chen, Hongwei Cheng

|Dec 18, 2023
New insights into the role of GSK-3β in the brain: from neurodegenerative disease to tumorigenesis.

Shenjin Lai, Peng Wang, Jingru Gong

|Nov 30, 2023
Febuxostat ameliorates APAP-induced acute liver injury by activating Keap1/Nrf2 and inhibiting TLR4/NF-κB p65 pathways.

Jinhong Tian, Shuaishuai Zhang, Lu Li

Pageof 2

Frequent Collaborators

2 joint publications

Hongwei Cheng

2 joint publications

Kaizhao Chen

2 joint publications

Jianxin Pang

1 joint publications

Alice Sze Tsai Wong